A 4699 New Jersey General Assembly · 2026-2027 Regular Session

Requires health insurance carriers to cover genetic testing after diagnosis of pancreatic cancer.

This New Jersey bill requires all health insurance plans in the state to cover genetic testing for individuals diagnosed with pancreatic cancer. The law applies to hospital service corporations, medical service corporations, health service corporations, and individual health insurance policies issued or renewed after the bill takes effect. Genetic testing includes tests that examine DNA, RNA, chromosomes, or proteins to identify mutations linked to pancreatic cancer and guide treatment decisions. The bill mandates that these tests be covered to the same extent as other medical conditions under each insurance contract.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2026
Committee Review
Floor Vote
Governor
Introduced Mar 16, 2026 Last action Mar 16, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Mar 16, 2026
Introduced
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
lower
2 primary · 0 co-sponsors

Sponsors